Viewing Study NCT02355535


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-04-14 @ 8:07 PM
Study NCT ID: NCT02355535
Status: COMPLETED
Last Update Posted: 2020-09-24
First Post: 2015-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
Sponsor: Vanquish Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module